The Relative Strength (RS) Rating for Inspire Medical Systems entered a higher percentile Tuesday, as it got a lift from 62 to 72.
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating of over 80 in the early stages of their moves. See if Inspire Medical Systems can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Inspire Medical Systems is working on a consolidation with a 225.00 buy point. See if it can clear the breakout price in volume at least 40% above average.
The company posted 0% EPS growth in the latest quarterly report, while sales growth came in at 33%.
The company earns the No. 16 rank among its peers in the Medical-Products industry group. Globus Medical, Pro-Dex and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
